Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KES524 in Patients With Obesity Disease
NCT00165685Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sibutramine in obesity, sponsored by Eisai Co., Ltd.. Started Jul 2004; status: completed.
02
Drugs
sibutramine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00165685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165685.